Nordic Biosite gives TerraLyzer European debut at NBS 2015

Täby, Sweden: – Nordic Biosite, the leading Scandinavian supplier of validated biotechnology products, will take a prominent place as sponsor and exhibitor at the upcoming Norwegian Biochemical Society Contact Meeting (NBS 2015) in Svalbard.

The Nordic BioSite team on the company’s exhibition stand will be exhibiting some key new products from Zymo Research, including the recently developed TerraLyzer™.

Taking the lab to the field

This will be the first European appearance for the latest version of TerraLyzer, which is an innovative device that can be used to lyse microbes in soil, sediment, sludge, and fecal samples and can effectively process tough-to-lyse fungal, algal, plant, and animal tissues over a very wide range of operating temperatures.

Zymo Research developed the TerraLyzer as a cordless, hand-held electric drive unit mounted to a unique, proprietary lysis chamber. It can be used for vigorous sample disruption (bead beating) that allows the researcher to “Take the Lab to the Field” and to the site of sample collection.

About Nordic BioSite

Since the late 1990s, Nordic BioSite has become recognized as one of the pharma industry’s most innovative and customer-responsive supplier of high quality validated biotechnology products for research, diagnostics, immunology and molecular biology.

The company serves pharmaceutical, biotech, diagnostic and academic organizations with tens of thousands of different products in more than 30 different groups, ranging from antibodies to genetic vectors. These are sourced from selected manufacturers and laboratories in Europe, the Americas and Asia.

Nordic BioSite continuously introduces new products as a result of its own R&D, leveraged by close partnerships with manufacturers and feedback from customers.

Nordic BioSite’s company strapline, By Your Side™, defines a company ethos of partnering life science customers, helping to find the right products and services to help reach chosen goals across the whole spectrum of biotech research areas.

Nordic BioSite also operates as a CRO through its Finnish-based cGLP laboratory, BioSiteHisto. This offers a wide range of leading-edge research-based custom laboratory services including histology, immunochemistry, in vitro research and testing, antibody optimization, antibody conjugation and predesigned adenylated linkers for Next Generation sequencing.

About NBS 2015

The 51st Norwegian Biochemical Society Contact Meeting will take place over four days in Longyearbyen, Svalbard, opening on February 9 and closing with a banquet dinner on the night of February 13.

The conference events are distributed between Kulturhuset, Polarsenteret and Radisson Blu Polar hotels.

The conference will feature seven plenary lectures, with eminent keynote speakers including Prof. Wieland Huttner, a director of the Max Planck Institute of Molecular Cell Biology and Genetics, Dr. Stefan Hell from Max Planck’s Department of NanoBiophotonics, Prof. Andreas G. Ladurner, Chair of the Adolf Butenandt Institute of Physiological Chemistry, University of Munich, and Prof. Terje Johansen, leader of the Molecular Cancer Research Group at The Arctic University of Norway.

The programme also features a number of topic-focused Minisessions.

The NBS meeting is sponsored by seven leading international companies,including Nordic BioSite and features a commercial exhibition.

More information at: http://nbs.h.uib.no